ACTHAR® STUDY - Membranous Nephropathy (H-29014)
This study will compare ACTHAR Gel to placebo for treatment of persistent proteinuria and nephrotic syndrome due to idiopathic membranous nephropathy (iMN). Study drug (or placebo) will be given as injections 2 times a week for 6 months with 6 months of follow up.
Site: Harris Health Smith Clinic
Study Doctor: Rajeev Raghavan, M.D.
Study Contact: Patricia Marino (713) 798-4516 or email@example.com
Open and actively recruiting